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Abstract 
Acute stress increases resistance to infection. The alteration of this mechanism in chronically stressed people impairs the 
organism’s ability to mount a strong immune response with a resultant increase in morbidity. Acute stress induces a probable 
sympatho-adrenergically mediated increase in chemotaxis and adhesion molecules expression, thus promoting immune cells 
migration to sites of infection and/or inflammation, while chronic stress impairs this mechanism. Protracted stressful conditions 
decrease NK cytotoxic capacity. There is a substance P, which under stressful circumstances mediates the increase in macrophage 
cytokine production. Acute stress increases T cell mobilization through a β2-adrenergically mediated process, which is blunted 
during chronic stress. Psychological stress impairs the immune system’s ability to produce antibodies in response to a vaccine, 
thereby making the organism more vulnerable to infections.  
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Abbreviations: CRH = corticotrophin-releasing hormone; HPA = hypothalamic-pituitary-adrenocortical; IL = interleukin; 
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Introduction 
Nowadays it is a proven fact that psychological 
stress increases the susceptibility to inflammatory 
disorders, including those of infectious etiology [1, 2, 3]. 
Great efforts are directed towards defining the precise 
pathways mediating this link. The old view was that 
stressful conditions have a depressing effect on immunity. 
However, the gathered evidence points towards a more 
nuanced vision: stress can both increase and decrease 
the bodily defenses, depending on a diversity of factors 
such as the duration of the stressful condition or the 
individual’s reaction thereto or perception thereof. Various 
ways of adapting to the stressful condition may have 
vastly different repercussions on immunity.  
Confronted with a stressful condition, the organism 
strives to cope. For millennia, the most often encountered 
stressors have been the pathogens attempting to 
penetrate the organism. Therefore, the mechanisms 
intended to have an adaptive function were evolutionarily 
designed for the confrontation with these intruders: 
structures that either bar their entry, or track them down 
and destroy them. The two main systems at work in this 
adaptive process are the nervous system (especially the 
brain) and the immune system. While reacting to a 
trespasser, there is a continuous interchange of message 
between these two systems in the attempt to keep the 
organism in balance and free of infecting organisms. The 
mechanisms responsible for the mediations of these 
interactions are both neuroendocrine and autonomic and 
form the object of a relatively new discipline: 
psychoneuroimmunology. As the name may suggest, the 
interactions it deals with are bidirectional: not only do the 
psychic alterations translate into immune changes, but 
also products of the immune cells influence neuronal 
circuits. The major pathways involved in these interactions 
are the hypothalamic-pituitary-adrenal (HPA) axis and the 
sympathetic nervous system (SNS). 
One of the key mediators is probably corticotrophin-
releasing hormone (CRH), which exerts a general 
immunosuppressive influence by enhancing the release of 
corticosteroids, catecholamines, and certain opiates 
through its action on the sympatho-adrenergic system. 
The release of CRH from the hypothalamus is modulated 
by behavioral, nervous, and neuroendocrine influences. 
Stress also modifies the secretion of growth hormone and 
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prolactin, which generally boost the immune system. 
Although increased early in the stress reaction, in the 
latter phases these hormones are decreased, being 
parallel to the similar evolution of the immune response to 
stress.  
The stimulation of the β2-adrenoreceptor unleashes 
the cAMP-protein kinase A pathway, which enhances the 
humoral immunity, while suppressing the cellular 
immunity. This change in dominance is exerted by both 
stimulating the activity of Th-2 cells and inhibiting the 
function of antigen-presenting cells and Th-1 cells. We 
may see this as an attempt to limit the deleterious effects 
of a non-specific defense reaction, while encouraging a 
more specific response confined to the aggressor. 
Therefore, under adrenergic stimulation, the defense 
reaction shifts from a general systemic inflammatory one 
to a specific localized long-term protective one. In order to 
achieve this, the systemic release of proinflammatory 
cytokines (IL-1, TNF-α, and interferon-γ) is shut down, 
while that of anti-inflammatory cytokines (IL-10 and TGF-
β) is stimulated. The proinflammatory cytokines (IL-1, 
TNF-α, and primarily IL-8) might still be released in the 
invaded/ injured region calling for neutrophil accumulation. 
The outcome of infectious disease is altered by the 
chronic exposure to stress [5,  6]. Long-term immune 
changes are one of the possible pathways through which 
chronic stress enhances the vulnerability to infectious, 
neoplastic, and autoimmune disease [7]. The chronic 
stress-related increased susceptibility to disease is 
attributable to perturbed homeostatic mechanisms – the 
term "allostatic load" was created in order to underline the 
idea that long-lasting adversity is apt to lead the bodily 
neurochemical activity away from its normal equilibrium 
(homeostatic) position, with persistent (or even 
permanent) negative impact on health [8]. 
One of the many forms of chronic stress is sleep 
deprivation, which was proven to interfere with the 
immune processes, altering the function of NK cells, the 
cytokine production, and the humoral immune responses 
to vaccination [9, 10, 11]. 
Altered endocrine mechanisms or maladaptive 
health practices could serve as a link between stress and 
impaired immunity [12,  13]. When the environmental 
challenges exceed the organism’s coping ability, major 
endocrine systems are activated, especially the 
sympathetic-adrenal medullary (SAM) system (including 
the SNS and the adrenal medulla) and the HPA system, 
with a resultant activation of the receptors for cortisol and 
catecholamines on the leukocytes. This alters cellular 
trafficking, proliferation and differentiation, and cytokine 
production [14]. 
The defense mechanisms encompass several 
systems, all of which are influenced by stress. These 
systems may be broadly divided into the innate immune 
system (including components such as the proteins 
secreted at mucosal surfaces and the cells involved in 
killing the bacteria) and the adaptive immune system, 
which has a more specific action and includes antibody 
production. 
 
The Effects of Stress on Epithelial Surfaces Protection 
The pathogens invasion implies the penetration of 
epithelial barriers: mucous membranes or skin. The skin’s 
protective mechanisms rely heavily on its thickness 
(mechanical protection). By contrast mucous membranes 
cannot be thick, given the secretion and/or absorption 
processes that are supposed to take place at their 
surface. Therefore, other protective mechanisms have 
been developed: certain proteins with more (S-IgA) or less 
(various secretory proteins) specific protective action 
(biological protection). All these protective mechanisms, 
both mechanical and biological, are influenced by stress. 
Skin serves as a barrier to prevent the entry of 
pathogens. It was shown that the recovery of the skin’s 
integrity is delayed in subjects exposed to acute stress 
[15, 16, 17]. This is in concordance with the protracted 
healing of wounds after short- and long-term psychological 
stress [18,  19]. The slow resolution of skin injuries is 
attributed to stress-induced neural, endocrine and immune 
alterations: activation of immune and inflammatory 
processes in the skin, neuropeptide release from the 
peripheral nerves, and increased systemic glucocorticoid 
levels [16]. These neural, endocrine and immune changes 
interfere with processes such as lipid synthesis and 
cytokine expression, important in the initial phases of 
wound healing [16, 20]. Research done on animal models 
proved the involvement of glucocorticoids [21, 22] and of 
β-adrenergic agonists in the delayed skin recovery from 
injury [23]. 
A wide range of secretory proteins protect the 
mucosal surfaces: some pertain to the (secretory) 
adaptive immune system, others to the innate one. The 
secretory immunoglobulin A (S-IgA) is a member of the 
adaptive secretory immune system. Its secretion is 
controlled by neuroendocrine factors and is consequently 
influenced by stress [2]. The duration of the stressful 
situation is particularly important: acute stress enhances 
S-IgA levels, in contrast to prolonged stress, which 
diminishes S-IgA levels [24]. 
The secretory proteins with antimicrobial activity are 
part of the innate immune system and act as a first line, 
nonspecific protective mechanism. They are produced by 
the exocrine glands lining the mucous membranes of the 
digestive, respiratory, and urogenital tracts. Their release 
is controlled by the neuroendocrine system, which 
provides the means through which psychosocial stress 
may exert its influence. It was proven that the secretion of 
salivary proteins (such as cystatin S, lactoferrin, α-
amylase, the mucins MUC5B and MUC7) is increased by 
stressful situations, not only by those requiring an active 
attitude (with predominantly sympathetic activation), but 
even more by those inducing a passive one (in which the 
vagal tone is predominantly increased). The pattern of 
proteins is also different: only MUC7, lactoferrin, and α-
amylase are increased when the sympathetic stimulation 
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is dominant, while all the proteins are increased in the 
vagal tone-increasing situation. This stress-induced 
change in the pattern and the quantity of salivary proteins 
may partially explain the way stress alters the 
susceptibility to infectious diseases [25]. This might have a 
considerable importance, since circumventing this first line 
of defense seems to be decisive in initiating an infectious 
disease.  
The occurrence of an infectious disease can be 
divided into two distinct phases: the infection (which refers 
to the microorganisms gaining access into the system), 
and the disease itself. The increased rate of infectious 
diseases in stressed individuals seems to be related 
primarily to an alteration of the first of these two phases: 
psychosocial stress mainly increases the proportion of 
infected persons, rather than the progression of infection 
to clinical disease [26]. The role of the secretory proteins 
is to prevent the infection; hence they are relevant in the 
assessment of the stress-related increase in the 
predisposition to infectious diseases. Protein secretion is 
primarily controlled by the SNS through β-adrenergic 
pathways.  
The effect of usual stressful factors on secretory 
immunity may be prolonged, lasting considerably more 
than the actual stressful situations. The exposure to acute 
stress increases mucin secretion in the digestive and 
respiratory tracts [27, 28], which should enhance mucosal 
barrier function. This may appear paradoxical given the 
increased rate of infection in individuals subjected to acute 
stress [25]. One explanation may be the adaptive 
mechanisms developed by the infecting organisms, 
allowing them to take advantage of the increased protein 
secretion [29]. One example is Helicobacter pylori; whose 
ability to bind certain types of mucin proteins enhances 
the organism’s potential to invade the host. It has been 
proven that under stressful circumstances, the increased 
secretion of MUC5B promotes the adherence of H. pylori 
[27].  
 
The Effects of Stress on the Cellular Immunity 
Acute stress accelerates both the resolution of an 
infection [30, 31] and the healing of a wound [32], and 
may result in an increase in both cellular and humoral 
immunity [33, 34, 35]. The mediator of these protective 
actions is, at least partially, the stress hormones-
orchestrated mobilization of immune-cells [36,  37]. 
Leukocyte redistribution is the mechanism designed to 
provide the adequate number of cells to the sites of 
invasion/ injury [36]. Chemotaxis and adhesion molecules 
expression are two critical processes in the recruitment 
and migration of immune cells to inflammatory sites, 
promoting the redeployment of leukocytes to places where 
they are most required in order to fight the potential 
aggressors. 
Immune cells continuously patrol the organism in 
the quest for intruders. They cover long distances via the 
circulation, and then exit the blood vessels in various 
tissues and organs where they exert their function. After a 
longer or shorter interval, they may reenter the blood 
vessels and continue to traffic through the body. 
Psychological stress may alter this pattern of circulation. 
This may have repercussions on the efficiency of the 
protective action belonging to the cellular branch of the 
innate immune system. By activating the adrenergic 
receptors, the acute stress-induced SAM system 
stimulation leads to an increase in immunoregulatory cell 
number and function [38, 39, 40], aimed at increasing the 
defense ability (it seems sensible that the stress-exposed 
organism should be more prepared for injury or invasion). 
However, many researchers have found that the immune 
response to acute stress in chronically stressed 
individuals is different from that in healthy persons [41], 
suggesting a disorder in the sympathetically mediated 
protective processes. 
 
The Effects of Stress on the Macrophages  
Cellular and humoral immune reactions heavily rely 
on macrophages, which are sensitive to stress. Stress 
augments cytokine production, which may explain the 
increase in acute phase reactants through the induction of 
their hepatic synthesis by cytokines such as IL-1 and IL-6. 
Substance P is involved in the stress-induced changes in 
cytokine levels and in the macrophage responses to 
stress [42]. 
 
The Effects of Stress on the NK Cells 
Acute stress leads to an increase in the number of 
circulating NK cells [13,  38] by promoting their release 
from various reservoirs [43]. In young subjects, there may 
also be an increase in NK cell activity [38]. In stressful 
circumstances the NK cells lining the walls of the blood 
vessels leave their waiting position, enter the blood flow, 
and circulate (through the mediation of various 
chemoattractants, citokines and ligands) to the various 
territories were they are needed. The aim of these NK cell 
mobilizations is to provide protection during acute stress. 
One of the factors mediating the effects of acute stress on 
NK cell function is probably the SAM system, through 
increased levels of NE and/or epinephrine [44].  
The cell-surface marker characteristic for NK cells is 
CD56 (besides, NK cells do not express CD3). 
Functionally, there are at least two subsets of NK cells:  
•  most of them exert a cytotoxic function and have 
a low surface density of CD56 (CD56poor); these are 
rich in CD11a adhesion molecules, whose ligands are 
profusely expressed on the endothelial cells close to 
the site of an inflammatory reaction; the high density of 
CD16 on CD56poor NK cells is instrumental in their 
ability to identify cells coated with antibody inviting NK 
cells to set free their destructive potential; 
•  the remainder, rich in CD56 (CD56rich), release 
cytokines, thereby modulating the function of the 
immune system is the major NK subtype found in the 
peripheral lymph nodes. This happens due to a high 
density of CD62L (L-selectin) adhesion molecules, 
which promote the migration of lymphocytes into the 
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secondary lymphoid tissues, whose high endothelial 
venules abundantly express CD62L-ligands. 
Common stressors lead to a marked increase in the 
number of cytotoxic CD56poor NK cells in the blood, which 
are meant to patrol the organism searching for either 
intruders or damaged tissue. The SNS activation is a 
crucial mediator of this process, and the amount of NK cell 
mobilization parallels the magnitude of other 
adrenergically mediated physiological changes [45,  46, 
47, 48, 49]. It was proven that sympatho-adrenergic tone-
increasing conditions (acute stressors, exercise, and 
catecholamine infusions) selectively increase the number 
of CD56poor NK cells in the blood [50, 51, 52]. This may be 
explained by the catecholamine’ ability to decrease the 
CD56 expression on the already circulating NK cells 
and/or to preferentially mobilize the CD56rich NK cells. The 
latter hypothesis is better supported by current evidence, 
pointing to a selective mobilization of NK cells during 
acute stress, according to differences in surface 
expression of adhesion molecules [50]. A likely 
explanation is a higher density and/or sensitivity of 
adrenergic receptors, which induces a higher 
responsiveness to catecholamines [51]. Correlatively, 
during acute stress, the number of circulating CD16 -rich 
in NK cells increases, thereby promoting the antibody-
dependent cytotoxicity [51]. On the other hand, chronic 
stress results in a decline in NK cytotoxic activity [13]. 
Therefore, stress seems to have at least some beneficial 
effects, in the short run, on the immune function and on 
health in general [36]. It is chronic stress that puts things 
wrong. 
The number of adhesion molecules on the NK cells 
changes in acutely stressful situations [50, 53, 54, 55]. 
Acute stressors down-regulate the expression of CD62L 
on circulating NK cells, while increasing the density of 
CD11a. Similar changes are induced by strenuous 
exercise or by pharmacologic stimulation of β-adrenergic 
receptors [52]. Beta-blockade has opposing effects [52, 
55]. We may conclude that stress-induced changes in 
adhesion molecule densities on circulating NK cells may 
be largely attributed to adrenergic hyperactivity. 
Conversely, chronic stress reduces the NK cell 
responsiveness to cytokines [56], with a drop in the NK 
cell activity, in contrast to the increased activity in normal 
individuals subjected to an acute stress. NE may be one 
of the factors mediating this effect, which was shown to 
reduce NK cytotoxic capacity in vitro [57]. Exposure to 
chronic stress results in a decreased NK cell ability to kill 
target cells [13], and diminished response to recombine 
interferon gamma [58], which may partially explain the 
chronic stress associated morbidity, as impaired NK 
function correlates with the development or progression of 
viral, autoimmune, and neoplastic diseases. However, the 
immune cell functional capacity recovers relatively quickly: 
it begins within 1 month and is substantial within 1 to 3 
months after the conclusion of the overtaxing situation 
[59]. Of course, this holds as long as no other major stress 
supervenes in the next few months. 
If exposed to an acute psychological challenge, 
chronically stressed individuals have a protracted decline 
in NK cell activity [41] and a more pronounced 
redistribution of NK cells. Normally, acute stress is 
associated with a hormonal upsurge in the SAM, HPA and 
endorphin systems. In individuals previously exposed to 
chronic stress, these acute stress-induced changes are 
altered, with an excessive adrenergic response and a 
blunted β-endorphinic one [41]. 
 
The Effects of Stress on the T lymphocytes 
A brief exposure to stress increases the number of 
circulating CD8 suppressor/cytotoxic T cells [38]. In 
healthy individuals acute stress induces not only 
lymphocytosis, but also a greater increase in 
CD8(+)CD62L(-) T cells compared to CD8(+)CD62L(+) T 
cells. This change may be partially prevented by prior 
treatment with the nonselective β-antagonist propranolol, 
but not by the β1 selective antagonist metoprolol [60]. In 
contrast, chronically stressed individuals have a drop in 
the percentage of circulating CD62L(-) T lymphocytes [61], 
which is associated with a decrease in the sensitivity and 
density of the β2-adrenergic receptors on lymphocytes 
[62] and therefore, a drop in the sympatho-adrenergic 
driven stimulation of immune cells. This may have 
consequences on the immune cells’ readiness to mobilize 
and migrate in response to acute stressors and implicitly 
on the organism’s ability to defend itself. 
Chronic stress decreases the lymphocyte 
proliferative ability in response to mitogens [63], to lectins, 
and to T-cell receptor activation [58]. It may also diminish 
the percentages of total T lymphocytes and of Th 
lymphocytes, and it may increase antibody titers to 
Epstein-Barr virus (as a consequence of the cellular 
immune system’s inability to control the latent virus) [64]. 
 
The Effects of Stress on Chemotaxis  
Normally, there is an increase in chemotaxis [65] in 
response to acute stress. However, in chronically stressed 
persons, the response to typical chemotactic agents is 
markedly reduced after exposure to an acute stress [66]. 
In healthy persons, epinephrine has an inhibitory effect on 
chemotaxis in normal circumstances, but a stimulatory 
one in response to acute stress, putting the organism in a 
better position to oppose pathogens. The opposite seems 
to be the case of individuals exposed to long-lasting 
stress: usually the chemotactic capacity develops parallel 
to the level of adrenergic activation, but the relation is 
reversed in acutely stressful situations. In other words, 
chemotaxis is active when it is needed in normal persons, 
in contrast to chronically stressed individuals, where 
chemotaxis fails when it is most needed and improves 
otherwise. Therefore, in persons exposed to chronic 
stress, lymphocytes no longer exert their protective role 
when necessary; instead they may induce pathological 
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changes (such as atherosclerosis) due to their unduly 
mobilization in baseline settings.  
Activation of Mac-1 (CD11b/CD18) by chemoattractant 
agents is involved in leukocyte recruitment to the sites of 
inflammation. The expression of Mac-1 on lymphocytes is 
increased during acute psychological stress [65], while the 
expression of L-selectin (CD62L) is decreased [67, 50]. 
Correspondingly, the catecholamine levels are positively 
associated with Mac-1 expression on lymphocytes and 
negatively associated with L-selectin (CD62L) expression. 
LFA-1 is a leukocyte integrin, involved in the recruitment 
to the site of infection, functioning as an adhesion 
molecule. The infusion of a β-adrenergic agonist (such as 
isoproterenol) increases LFA-1 expression on 
lymphocytes [68], and so does psychological stress [67, 
50], while β-blocking agents (e.g. propranolol) are known 
to reverse this response [55]. Hence, there is a general 
agreement that the changes in adhesion molecules 
expression are due to sympatho-adrenergic activation. 
However, besides the catecholamines, corticosteroids 
also seem to be involved in the stress-related changes in 
leukocyte trafficking [33]. 
 
The Effects of Stress on the Humoral Immunity 
Receptors of glucocorticoids (including cortisol) and 
catecholamines (epinephrine and NE) are found on each 
of the cell types associated with the primary and 
secondary antibody response. The increased plasma and 
tissue concentrations of these hormones during stressful 
conditions alter the function of these cells, and hence the 
antibody production. High levels of stress lead to a 
decrement in the titers of protective antibodies against 
various pathogens, such as influenza, hepatitis B, and 
pneumonia [69, 70, 71, 72, 73, 74]. There is convincing 
evidence about the impact of stress on the secondary 
antibody response to immunizations, but less so, about 
the primary one. The feebleness of the evidence regarding 
the primary response may be due to an inappropriate 
timing of the assessment, as it is assumed that there are 
some critical moments when the antibody response might 
be most vulnerable to stress. There may also be a 
difference between the effects of long- and short-lasting 
stress [12].  
It is believed that there may be a critical period (the 
10 days after the vaccine is administered) when stress is 
more apt to impair the antibody response [75]. Therefore, 
it seems that the latter stages of the antibody production 
(which involve cytokine production by activated T cells) 
are more vulnerable to stress than the earlier stages. This 
may have therapeutic consequences: psychological 
interventions are known to increase the humoral immune 
responses to vaccination [76] and they may be properly 
scheduled so as to have a maximal impact during the 
vulnerable period [77].  
Chronic stress is associated with a diminished 
antibody response to vaccines [12, 13]. This effect has 
been most consistently documented in persons caring for 
a spouse incapacitated with dementia [70, 71, 78, 69, 74, 
79]. A bleaker perspective on life might be responsible for 
this latter effect, as it has been proven that, besides 
stress, depression is also detrimental to humoral immunity 
[80]. Nevertheless, one should not forget the immune-
modulating effects of genetic factors (such as cytokine 
gene polymorphisms [80]).  
The effect of acute stress on antibody production 
seems to be less consistent (the impact on secretory 
immunoglobulin A production is better proven) and less 
durable (an association was found only when a tight timing 
in the assessment of stress and antibody production was 
observed). Acute stress at the time of antigenic challenge 
augments the antibody response to both thymus-
independent and thymus-dependent vaccines, proving 
that stress-induced immune enhancement is not 
dependent on T-cell involvement [81]. 
Cortisol is one of the pathways through which stress 
alters the antibody response to a vaccine [82]. Stress-
increased cortisol secretion is associated with a feeble 
antibody response to vaccination [69, 83, 82]. Prolonged 
stress chronically activates the HPA axis with persistent 
elevation of systemic glucocorticoids, which may put off 
balance the Th1/Th2 cytokine network by inhibiting 
cytokine synthesis. The resultant immune disorders 
predisposes to a wide range of diseases [84, 85, 86, 87]. 
Other hormones (such as epinephrine and NE, prolactin, 
and growth hormone) could also be involved in mediating 
the link between stress and secondary antibody response 
[88].  
Besides the endocrine alterations, lifestyle changes 
(alteration of alcohol consumption, cigarette smoking, 
physical activity, and sleep) may act as mediators, linking 
stress exposure to antibody response [3,  89]. Indeed, 
smoking, physical inactivity, and sleep deprivation are 
known to decrease antibody responses to vaccination [90, 
9]. Altered sleep patterns also seem to be responsible for 
the impaired immune response following exposure to 
stress [91, 92]. Sometimes, a vicious circle may arise, in 
which sleep deprivation and feelings of stress promote 
each other [75] to the detriment of humoral immunity. 
Psychological interventions aimed at improving 
stress coping abilities may improve the immune response 
to vaccines [79]. 
Conclusions 
Brief acute stressful situations have a stimulating 
effect on immunity, associated with the general SAM 
activation, which promotes the redistribution of immune 
cells from the blood to other organs in the body. However, 
enduring stress, which is known to result in down-
regulation of β-adrenergic receptors, alters adhesion 
molecules expression on leukocytes, with a resultant 
decrease of immune response to acute psychological 
challenges in chronically stressed persons.  
In contrast to acute stress, chronic stress impairs NK and 
T cell function.  
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Stress modulates the antibody response to 
vaccinations. Chronic stress-induced by enduring hardship 
is clearly associated with a decrease in the secondary 
antibody responses to immunization, especially in older 
adults. 
The immune alterations in stress-generating 
situations are probably due to hormones (most likely, 
glucocorticoids and catecholamines) binding to their 
specific receptors. Behavioral or neurobiological 
mechanisms might also be operational, as bad life habits 
(smoking, alcohol consumption, insufficient sleep, poor 
diet etc.) have well-established repercussions on 
immunity.  
Proper counseling and psychological support may 
appease the deleterious effects of chronic stress, helping  
 
exposed individuals to preserve the strength of their 
immune system. 
Increasingly, the sympathetic nervous system (SNS) 
is considered a key mediator, and norepinephrine (NE) is 
a serious candidate for the role of neurotransmitter/ 
neuromodulator in the lymphoid organs [4]. There are 
receptors for catecholamines on the immune cells. The 
increase in the sympatho-adrenergic tone in response to a 
stressor results in local and systemic changes is 
represented by a release of NE from the nervous 
terminals in the lymphoid organs, in association with 
increased circulating levels of epinephrine. Subjected to 
this adrenergic environment, the lymphocytes change their 
pattern of proliferation, circulation, and cytokine 
production.  
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